IPP Bureau
Briefs: IOL Chemicals and Pharmaceuticals and Auro Peptides
By IPP Bureau - February 20, 2024
IOL Chemicals and Pharmaceuticals’ product approved by CDE of NMPA, China
GSK completes acquisition of Aiolos Bio
By IPP Bureau - February 19, 2024
The acquisition of Aiolos includes AIO-001, a potentially best-in-class, long-acting antithymic stromal lymphopoietin (TSLP) monoclonal antibody
Evonik, University of Mainz to commercialize a new class of PEG lipids for nucleic acid delivery
By IPP Bureau - February 18, 2024
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
Precision Optics enters into production and technology licensing agreement for single-use ophthalmic program
By IPP Bureau - February 17, 2024
The agreement sets terms under which POC will manufacture the product or receive royalties
Modi lays foundation stone of AIIMS Rewari in Haryana
By IPP Bureau - February 17, 2024
AIIMS Rewari is a 750-bed hospital complex which includes a 100 seat medical college, a 60 seat nursing college, a 30-bed AYUSH block
Lupin receives approval from USFDA for Minzoya
By IPP Bureau - February 17, 2024
Minzoya Tablets are indicated for use by females of reproductive potential to prevent pregnancy
Zydus receives USFDA approval for Isosorbide Mononitrate Extended-Release, Tablets USP
By IPP Bureau - February 17, 2024
Isosorbide mononitrate is used to prevent chest pain (angina) in patients with a certain heart condition (coronary artery disease)
Internal restructuring of foreign subsidiaries at Bliss GVS Pharma
By IPP Bureau - February 17, 2024
The restructuring aims to create synergies across the business and strengthen capital structure
YS Biopharma appoints new Directors
By IPP Bureau - February 17, 2024
The Board has elected Dr. Ajit Shetty, who had served as the Company's Interim Chairperson of the Board since December 9, 2023, as Chairperson of the Board, effective February 13, 2024
Ginkgo, SaponiQx to discover and manufacture next-gen vaccine adjuvants
By IPP Bureau - February 17, 2024
Adjuvants are components of vaccines that help to enhance the magnitude, breadth, and duration of the immune response to vaccination
Blacksmith Medicines and Zoetis collaborate for novel animal health antibiotics
By IPP Bureau - February 17, 2024
Through our research, we aim to ultimately provide new options for our customers to treat life-threatening infections in livestock
Glenmark Pharma posts Q3 FY24 net loss of Rs. 331 Cr
By IPP Bureau - February 16, 2024
he lower sales in the current quarter are mainly on account of a one?time impact on the company’s India business
Marksans Q3 FY24 revenue up 22% at Rs 586 Cr
By IPP Bureau - February 16, 2024
Gross profit was Rs. 313.3 crore, up by +30.4% YoY with a Gross margin of 53.5%
Lupin launches Ganirelix Acetate Injection in US
By IPP Bureau - February 16, 2024
It is indicated for the inhibition of premature luteinizing hormone (LH) surges in women undergoing controlled ovarian hyperstimulation
Healthcare Triangle unveils new SaaS Solutions to drive AI integration in healthcare
By IPP Bureau - February 16, 2024
The company's SaaS solutions are tailored to enhance accessibility, efficiency, and patient-centricity in healthcare operations
